Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Farmers Insurance
Cerilliant
US Department of Justice
Merck
Covington
Boehringer Ingelheim
Teva
McKesson
Argus Health

Generated: February 19, 2019

DrugPatentWatch Database Preview

Drugs in Development Information for Omecamtiv Mecarbil

« Back to Dashboard

US Patents for Omecamtiv Mecarbil

Glossary
Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
Omecamtiv Mecarbil ➤ Sign Up Compounds, compositions and methods Cytokinetics, Inc. (South San Francisco, CA) ➤ Sign Up
Omecamtiv Mecarbil ➤ Sign Up Compounds, compositions and methods Cytokinetics, Inc. (South San Francisco, CA) ➤ Sign Up
Omecamtiv Mecarbil ➤ Sign Up Disubstituted ureas and uses thereof in treating heart failure Amgen, Inc. (Thousand Oaks, CA) ➤ Sign Up
Omecamtiv Mecarbil ➤ Sign Up Ureas and their use in the treatment of heart failure Cytokinetics, Inc. (South San Francisco, CA) ➤ Sign Up
Omecamtiv Mecarbil ➤ Sign Up Certain Chemical entities, compositions and methods Cytokinetics, Inc. (South San Francisco, CA) ➤ Sign Up
Drugname Patent Number Patent Title Patent Assignee Estimated Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

International Patents for Omecamtiv Mecarbil

Glossary
Drugname Country Document Number Estimated Expiration Related US Patent
Omecamtiv Mecarbil Argentina 053405 2024-06-17 ➤ Sign Up
Omecamtiv Mecarbil Australia 2005264988 2024-06-17 ➤ Sign Up
Omecamtiv Mecarbil Brazil PI0512193 2024-06-17 ➤ Sign Up
Omecamtiv Mecarbil Canada 2570999 2024-06-17 ➤ Sign Up
Omecamtiv Mecarbil China 101035525 2024-06-17 ➤ Sign Up
Drugname Country Document Number Estimated Expiration Related US Patent

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Argus Health
US Army
McKesson
Deloitte
Teva
Medtronic
QuintilesIMS
Covington
Federal Trade Commission

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2019 thinkBiotech LLC
ISSN: 2162-2639
Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions
Site Map
Major Patent Expirations 2019 - 2020
Preferred Citation:
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2019, www.DrugPatentWatch.com.
Links

Follow DrugPatentWatch: